Zidovudine, Lamivudine and Nevirapine Tablets (300mg+150mg+200mg)

Zidovudine, Lamivudine and Nevirapine Tablets (300mg+150mg+200mg) Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Zidovudine, Lamivudine and Nevirapine Tablets IP 300mg+150mg+200mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Zidovudine, Lamivudine and Nevirapine Tablets IP 300mg+150mg+200mg
Each film-coated tablet contains:
Zidovudine IP…………….300mg
Lamivudine ……………….150mg
Nevirapine …………………200mg
Excipients……………………q. s
Color: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

The combination of lamivudine and zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Lamivudine and zidovudine are in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). They work by decreasing the amount of HIV in the blood.

CAUTION & SHEDULE:

CAUTION: Do not use if seal over bottle opening is broken or missing.
Dispense in a tight, light-resistance, container.
Keep store in tightly closed container.
Dispense in original container.
DO NOT BREAK OR CRUSH TABLET.

SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner Only.

STORAGE & DOSAGE:

STORAGE: Protect from Light & moisture at temperature not exceeding 30°C. Keep in cool & Dry place.
Keep medicine out of reach of children.
Read enclosed leaflet before use.

Dosage: AS DIRECTED BY THE PHYSICIAN.

Introduction to Zidovudine, Lamivudine and Nevirapine Tablets (300mg+150mg+200mg)

What It Is & Its Pharmacological Importance

The Zidovudine, Lamivudine and Nevirapine combination is a powerful triple ARV regimen used for the management of HIV-1 infection in adults and adolescents. It works by:

• Blocking reverse transcriptase enzymes

• Reducing HIV viral replication

• Increasing CD4 lymphocyte count

• Strengthening the immune system

This combination therapy is vital for millions of patients across Africa, Asia, Latin America, and CIS countries.

Global Market Demand

The global HIV drug market continues to grow due to:

• Increasing access to treatment in low-income countries

• Government-funded HIV programs

• Donor-funded procurements (UNICEF, WHO, PEPFAR, NGOs)

• Rising prevalence of HIV in emerging markets

India—especially Taj Pharma—plays a crucial role as one of the primary suppliers of quality-assured antiretrovirals to global markets.

 Comprehensive Export Support for Global Buyers 

Taj Pharma stands out as a trusted partner for importers, distributors, and government tenders worldwide. The company offers a complete regulatory, logistical, and commercial support structure.

 Regulatory Documentation Provided

Taj Pharma provides full regulatory and quality documentation including:

• WHO-GMP Certificate

• EU-GMP (available for select facilities)

• Certificate of Pharmaceutical Product (COPP)

• Free Sale Certificate (FSC)

• Certificate of Analysis (COA)

• MSDS (Material Safety Data Sheet)

• FDA-compliant stability data

• CTD/ACTD Dossier (Module 1–5)

• Bioequivalence (BE) data (if required by market)

• Batch manufacturing and packaging records

Importers receive all documents needed for product registration, tenders, wholesale distribution, and government procurement.

 Custom Packaging, Labeling & Export-Ready Options

Taj Pharma offers:

• Custom artwork designing

• Private labeling / contract manufacturing

• Multilingual packs (French, Spanish, Arabic, Russian, Swahili, etc.)

• Packing as per buyer’s regulatory norms

• Tamper-proof blister and bottle packaging

• Bulk export packs for institutional supply

 Shelf-Life, Storage & Dosage Form

• Shelf-life: 24–36 months

• Storage: Below 30°C, protected from light & moisture

• Dosage form: Film-coated tablets in blister or bottle packs

• Presentation: 10×10, 3×10, 1×60, or customized

 Export Certifications

Taj Pharma manufacturing facilities hold top-tier global certifications:

• WHO-GMP Certified

• ISO 9001:2015

• GLP Certified Labs

• NABL Accredited QC labs

• GMP Schedule M Compliance

• CE & FDA compliance for related products

• GMP-approved clean-room infrastructure

 Target Countries & Export Markets

Taj Pharma exports Zidovudine, Lamivudine and Nevirapine Tablets (300mg+150mg+200mg) to:

• Africa (Nigeria, Uganda, Kenya, Tanzania, Ethiopia, Ghana)

• Latin America (Peru, Bolivia, Guatemala, Honduras)

• Southeast Asia (Philippines, Cambodia, Myanmar)

• CIS (Ukraine, Georgia, Kazakhstan)

• Middle East (Yemen, Iraq, UAE)

• Caribbean (Jamaica, Trinidad & Tobago)

 Why Taj Pharma Is the Most Trusted ZLN Tablet Manufacturer in India

1. State-of-the-Art Manufacturing Systems

Taj Pharma’s world-class facility in Vapi, Gujarat, features:

• Automated high-speed tablet lines

• HEPA-filtered clean rooms

• Dedicated ARV manufacturing zones

• International-standard QC labs

• Advanced stability chambers

These ensure consistent potency, purity, and bioavailability.

2. Affordable Pricing with Global Standard Quality

Taj Pharma aims to make life-saving HIV treatments accessible by offering:

• Competitive ex-factory pricing

• Tender-friendly quotations

• Long-term contract manufacturing rates

• Bulk order discounts

3. Global Distribution & Supply Chain Strength

With a strong logistics network, Taj Pharma ensures:

• On-time deliveries

• Temperature-controlled shipments

• Seamless customs clearance

• Large production capacity for government tenders

4. Top 20 Countries  

India | Vietnam | UAE | Saudi Arabia | Kenya | Tanzania | Nigeria | Philippines | Cambodia | Ghana | Peru | Colombia | Uzbekistan | Kazakhstan | Sri Lanka | Myanmar | Yemen | Oman | South Africa | Chile

Technical Product Specification Table

Call to Action

Looking for a reliable, WHO-GMP-certified manufacturer of Zidovudine, Lamivudine and Nevirapine Tablets (300mg+150mg+200mg)?

Taj Pharma is your ideal partner for:

✔ Bulk exports
✔ Government tenders
✔ Institutional supply
✔ PCD Pharma Franchise
✔ Contract manufacturing & private labeling

📩 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
📞 Global Sales:  +91 74 0000 9975 / +91 74 0000 9976 (WhatsApp Support)

 Top 20 FAQs  

1. What are Zidovudine, Lamivudine and Nevirapine Tablets used for?

They treat HIV-1 infection by reducing viral load and increasing CD4 count.

2. Is Taj Pharma a WHO-GMP manufacturer?

Yes, Taj Pharma is fully WHO-GMP certified.

3. Can these tablets be exported worldwide?

Yes, Taj Pharma exports to 70+ countries.

4. What pack sizes are available?

10×10, 3×10, 1×60, and custom options.

5. Do you provide product dossiers?

Yes, CTD/ACTD dossiers are available.

6. Do you offer private labeling?

Yes, buyers can request custom branding.

7. What is the shelf life?

Generally 24–36 months.

8. What certifications are provided?

COPP, FSC, COA, WHO-GMP, MSDS, stability data.

9. Is bioequivalence data available?

Can be provided where required.

10. What is the minimum order quantity?

MOQ varies by market but generally 100,000 tablets.

11. Do you supply to tenders?

Yes, Taj Pharma participates in global HIV tenders.

12. Are multilingual packs available?

Yes—French, Spanish, Arabic, and others.

13. What is the lead time for production?

Typically 3–4 weeks.

14. How are the tablets shipped?

Via air or sea with temperature-controlled logistics.

15. What is the dosage regimen?

As prescribed by physicians—typically once daily.

16. Do you supply samples?

Yes, samples can be arranged for registration.

17. Do you have FDA approval?

Manufacturing is FDA-compliant; approvals vary by product.

18. Can we get best bulk pricing?

Yes—special pricing available for large orders.

19. Are these tablets safe for long-term use?

Yes, when used under medical supervision.

20. Why choose Taj Pharma?

Quality, trust, global reach, and WHO-standard manufacturing.